Shikonin exerts antitumor activity in Burkitt’s lymphoma by inhibiting C-MYC and PI3K/AKT/mTOR pathway and acts synergistically with doxorubicin
Crossref DOI link: https://doi.org/10.1038/s41598-018-21570-z
Published Online: 2018-02-20
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ni, Fan
Huang, Xianbo
Chen, Zhenzhen
Qian, Wenbin
Tong, Xiangmin
Text and Data Mining valid from 2018-02-20
Version of Record valid from 2018-02-20
Article History
Received: 15 November 2017
Accepted: 6 February 2018
First Online: 20 February 2018
Competing Interests
: The authors declare no competing interests.